Slingshot members are tracking this corporate initiative:
Teva and AbCellera Enter Into Agreement to Discover Rare Monoclonal Antibodies
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Feb 02, 2016 Projected Implementation: Q1, 2016 Relevance Tracked Until: Q1, 2017
Don’t see a project related to the strategic initiative you care about?
Related Keywords Monoclonal Antibodies